NASDAQ · BIVI
BioVie Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BIVI: Nov 9, 2026
BioVie Inc. Class A Common Stock is estimated to report earnings on 11/09/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.98.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks- RTTNews · Oct 19, 12:39 PM EDTBioVie's Bezisterim Shows Positive Signals In Long COVID Patients With Greater Symptom Burden(RTTNews) – BioVie Inc. (BIVI), a clinical-stage biopharmaceutical company developing therapies for neurological disorders, announced that it presented Phase 2 data on investigational bezisterim (NE3107) for Long COVID at the 151st Annual Meeting of the American Neurological Asso
- RTTNews · Sep 15, 8:24 AM EDTBioVie's Bezisterim Shows Phase 2 Signal In Long COVID; Stock Down(RTTNews) – BioVie Inc. (BIVI) announced topline results from its Phase 2 ADDRESS-LC trial evaluating Bezisterim in patients with neurological symptoms associated with Long COVID.
- RTTNews · Sep 15, 4:59 AM EDTBioVie To Present Phase 2 ADDRESS-LC Topline Data On Bezisterim's Potential In Long COVID; Today(RTTNews) – BioVie Inc. (BIVI) will host a conference call and webcast on September 15, 2026, at 8:30am ET to discuss topline results from its Phase 2 ADDRESS-LC trial evaluating Bezisterim.
- RTTNews · Aug 31, 12:50 PM EDTBioVie Doses Final Patient In Phase 2 Trial For Bezisterim In Long COVID; Stock Up(RTTNews) – BioVie Inc. (BIVI), a clinical-stage biopharmaceutical company, on Monday reported dosing the last patient in the Phase 2 ADDRESS-LC trial for Bezisterim in treating neurological symptoms of Long COVID.
- RTTNews · Aug 20, 10:38 PM EDTAfter-hours Gainers: HOWL Jumps 90%, MODD To Begin Pivot Pump Rollout, BIVI Awaits Long COVID Data(RTTNews) – The SPDR S&P Biotech ETF (XBI), a broad benchmark for the U.S. biotech sector, fell 3.64% during regular trading Thursday but edged 0.21% higher in after-hours trading. Among the notable biotech gainers in after-hours trading were Werewolf Therapeutics, which is advan
- RTTNews · Aug 18, 9:59 PM EDTAfter-Hours Biotech Gainers: TNON, BIVI, EDSA, RNAZ, HCWB(RTTNews) – Today's after-hours gainers include Tenon Medical, which recently reported its second-quarter results and implemented a reverse stock split; BioVie, which is developing a drug for early-stage Parkinson's disease; and Edesa Biotech, which is advancing EB06, a potential
- RTTNews · Aug 13, 4:28 AM EDTBiotech Stocks At 52-Week Highs – BIVI +22%, XNCR, ANRO, HAE, ACAD(RTTNews) – The following biotech stocks reached a 52-week high on August 12, 2026, driven up by key catalysts such as positive quarterly reports or promising results from clinical trials.
- RTTNews · Aug 7, 11:45 AM EDTWeekly Buzz: MRNA, NVS, SNY Gain Approvals; EBS, LSTA Cut Jobs; TARS, BIVI Drive Deals & Data(RTTNews) – This week's biotech roundup captured a mix of regulatory wins, restructuring action, and deal momentum driving sector sentiment. FDA and EU approvals spanned oncology, vaccines and rare disease, while layoffs and cost-saving measures underscored operational tightening
- RTTNews · Aug 6, 9:44 AM EDTBioVie Phase 2 SUNRISE-PD Meets Endpoint; Placebo Arm Showed More Adverse Reaction; Stock Down(RTTNews) – Key Highlights:
- RTTNews · May 26, 11:27 AM EDTBioVie Completes Enrolment In Phase 2 ADDRESS-LC Trial For Bezisterim In Treating Long COVID(RTTNews) – BioVie Inc. (BIVI), a clinical-stage biopharmaceutical company, on Tuesday reported complete enrollment in the Phase 2 ADDRESS-LC trial for Bezisterim in treating neurological symptoms of Long COVID.
- Zacks · Dec 11, 12:00 PM ESTWhat Makes BioVie (BIVI) a New Buy StockBioVie (BIVI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- RTTNews · Nov 20, 11:39 PM ESTBiotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound(RTTNews) – Trading after the bell was relatively muted on Thursday, with small-cap biotech names showing modest shifts. Delcath Systems edged higher following its buyback announcement, while BioVie, Cassava Sciences, and Enlivex Therapeutics rebounded despite a lack of fresh hea
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for BioVie Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.